DSETHVASAN: A NOVEL NANODRUG AGAINST SLEEPING SICKNESS

Author:

SETH D.1,BRAHMACHARY R. L.1,ULRICHS C.2,MONDAL M.3,MUKHOPADHAYAY S.3,SASMAL N. K.3,CHANDRA R.4,GUPTA S.5,GOSWAMI A.1

Affiliation:

1. Biological Sciences Division, Indian Statistical Institute, Kolkata-700108, West Bengal, India

2. Institute for Horticultural Science, Urban Horticulture, Humboldt University, Lentzeallee 75, Berlin-14195, Germany

3. Department of Veterinary Parasitology and Veterinary Pathology, West Bengal University of Animal and Fisheries Sciences, Kolkata-700037, West Bengal, India

4. Institute Instrumentation and Centre of Nanotechnology, Indian Institute of Technology, Roorkee, Uttaranchal-247667, India

5. Pathowynd Clinical Laboratory, Kolkata-700004, West Bengal, India

Abstract

Sleeping sickness (causal agent, Trypanosoma sp. parasite) causes huge morbidity and mortality in Africa (both human and livestock) in particular and zoo animals worldwide. Three of the four currently approved drugs (Pentamidine, Melarsoprol, Eflornithine, and Nifurtimox) were developed over 50 years ago. Current therapies are unsatisfactory due to unacceptable level of side effects. Pentamidine, an aromatic diamidine, safest so far, inhibits mitochondrial enzymes. Furthermore, it is effective only in early stages of infections and not on the later stage. Melarsoprol, practically insoluble in water, is very toxic and it is given intravenously (i.v.) for later stage infections only. Other drugs like eflornithine and nitfurtimox are also unsatisfactory for various reasons. Human serum derived high-density lipoprotein (HDL; not mouse or any other mammalian HDL) shows trypanolytic effect in vitro and in vivo on T. brucei. But the mechanism of action of human HDL is far from clear. In the absence of novel drug leads, nanodrugs might be valid options as nanoparticles show better accessibility to cells, supramolecular interactions due to enormous increase in surface area to volume ratio, altered partition coefficient, etc. Surface-modified hydrophobic microsilica (FS), mixture of micro- and nanosilica (Dsethvasan) and nanosilica (AL) were characterized by UV–Vis, DLS, SEM, EDAX, AFM, and XRD. Trypanosoma evansi collected from infected horses were injected in mice. Control infected mouse (n = 30) showed 100% mortality within 72±24 h of injection. Dsethvasan-treated mice (n = 30) survived for 192±24 h. FS-treated mice (n = 30) survived for 120±24 h but the AL-treated mice (n = 30) died within 72±24 h of inoculation like infected control. Hydrophobic Dsethvasan which consists of pure amorphous forms of micro- and nanosilica works better than FS (AL is not at all effective). Therefore, micro- and nanomixture of amorphous silica is best suited for treating Trypanosoma infection in mice. The possible role of ratio of higher to lower size class has been discussed.

Publisher

World Scientific Pub Co Pte Lt

Subject

Electrical and Electronic Engineering,Computer Science Applications,Condensed Matter Physics,General Materials Science,Bioengineering,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3